Diabetic Macular Oedema and Chronic Kidney Disease: Response to treatment with anti-vascular endothelial growth factor (VEGF)

Alice Bruynseels(Moorfields Eye Hospital NHS Foundation Trust), Ranjan Rajendram(University College London), Rita Pinto(Moorfields Eye Hospital), Dawn A. Sim(Moorfields Eye Hospital NHS Foundation Trust)

Investigative Ophthalmology & Visual Science

September 26, 2016

Cited by 0

Related Papers

A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)

|Ophthalmology|2010|510

Patterns of Peripheral Retinal and Central Macula Ischemia in Diabetic Retinopathy as Evaluated by Ultra-widefield Fluorescein Angiography

|American Journal of Ophthalmology|2014|142

Reevaluating the Definition of Intraretinal Microvascular Abnormalities and Neovascularization Elsewhere in Diabetic Retinopathy Using Optical Coherence Tomography and Fluorescein Angiography

|American Journal of Ophthalmology|2014|87

Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting

|American Journal of Ophthalmology|2016|86

Quantitative Analysis of Peripheral Vasculitis, Ischemia, and Vascular Leakage in Uveitis Using Ultra-Widefield Fluorescein Angiography

|American Journal of Ophthalmology|2015|85